Tremfya indct 200MG/2ML X2 pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJK7S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,725
Award facts
- Contract value 100% obligated
- $58,724.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $58,724.70 delivery order to AmerisourceBergen Drug Corp for TREMFYA (guselkumab) induction therapy, specifically 200 mg/2 mL pens (quantity of 2 pens, 2 mL each). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 30, 2026. The award was made on January 29, 2026, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor that plays a critical role in the federal medical procurement supply chain. The company consistently fulfills competitively awarded contracts with the DLA and other federal healthcare agencies, delivering a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This particular award for TREMFYA, a psoriasis treatment used in induction therapy protocols, reflects the contractor's capability to supply specialized pharmaceutical commodities to support military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FJK7S?
SPE2DR26FJK7S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJK7S worth?
The government has obligated $58,725 on SPE2DR26FJK7S.
Is contract SPE2DR26FJK7S an order under another contract?
Yes. SPE2DR26FJK7S is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK7S competed?
The extent of competition for SPE2DR26FJK7S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award